Search hospitals
>
California
>
Los Angeles
Los Angeles County-USC Medical Center
Claim this profile
Los Angeles, California 90033
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for AIDS
499 reported clinical trials
46 medical researchers
Summary
Los Angeles County-USC Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Cancer, Lung Cancer, AIDS and other specialties. Los Angeles County-USC Medical Center is involved with conducting 499 clinical trials across 731 conditions. There are 46 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.
Top PIs
Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Heinz-Josef Lenz
USC / Norris Comprehensive Cancer Center
8 years of reported clinical research
David Hong, MD
M D Anderson Cancer Center
4 years of reported clinical research
Jacob Thomas, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Clinical Trials running at Los Angeles County-USC Medical Center
Cancer
Bladder Cancer
Prostate Cancer
Breast Cancer
Kidney Cancer
Esophageal cancer
Pancreatic Cancer
Colorectal Cancer
Small Cell Lung Cancer
Lung Cancer
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting
2 awards
Phase 3
26 criteria
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting
2 awards
Phase 3
10 criteria
Atezolizumab +/− Selinexor
for Sarcoma
This trial is testing if atezolizumab alone or with selinexor can shrink tumors in patients with a rare type of cancer called alveolar soft part sarcoma. Atezolizumab boosts the immune system to fight cancer, and selinexor stops cancer cells from growing. The goal is to see if these treatments work better than the usual care.
Recruiting
1 award
Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Los Angeles County-USC Medical Center?
Los Angeles County-USC Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Cancer, Lung Cancer, AIDS and other specialties. Los Angeles County-USC Medical Center is involved with conducting 499 clinical trials across 731 conditions. There are 46 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.
Where is Los Angeles County-USC Medical Center located?
**Los Angeles County-USC Medical Center** - **Address:** 1200 N State St, Los Angeles, CA 90033. - **Public Transit:** Bus lines 251 and METRO J LINE 910/950 or B and D subway lines. - **Driving:** Utilize real-time driving directions for the best route based on current traffic updates and road conditions.
Who should I call to ask about financial aid or insurance network?
**Los Angeles County-USC Medical Center Financial Assistance Information:** - For Medi-Cal applications and inquiries, contact the DPSS Customer Service Center at (866) 613-3777. - The "Ability to Pay Program" (ATP) provides free services for patients with income at or below 200% Federal Poverty Level (FPL) and reduced-cost services on a sliding scale for those above 200% FPL. - For assistance with bill payments, contact patient financial services, available Monday to Friday, 8:00 am to 4:00 pm.
What insurance does Los Angeles County-USC Medical Center accept?
The Los Angeles County-USC Medical Center accepts a range of insurance plans, such as Medicare, PPO, and Self Pay. For a detailed list of accepted insurance plans, please contact the hospital directly or visit their official website.
What awards or recognition has Los Angeles County-USC Medical Center received?
Los Angeles County-USC Medical Center (LAC+USC) is renowned for its high-quality care, especially given its limited resources. In 2022, its initiative to reduce patient falls in the acute-care medical surgical jail ward earned recognition in the Excellence and Innovation in Care 2022 Gage Awards by America's Essential Hospitals. This accolade highlights LAC+USC's commitment to enhancing patient outcomes and advancing healthcare equity.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.